RABEVIB DSR

RABEPRAZOLE 20mg. IP + DOMPERIDONE 30mg. IP

Send Enquiry

PRIMA

Capsules

Packaging and packing Type

Alu Alu | 10x10

MRP :

₹138

PTR :

₹98.57

PTS :

₹88.71

An anti-ulcer and anti-emetic combination that addresses acid reflux, nausea and vomiting, and different types of ulcers. Demonstrates a significant ... Read More

Composition

RABEPRAZOLE 20mg. IP + DOMPERIDONE 30mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

An anti-ulcer and anti-emetic combination that addresses acid reflux, nausea and vomiting, and different types of ulcers. Demonstrates a significant and remarkable improvement in symptoms of gastroesophageal reflux disease. (Savita Shahani, 2008) Effectively addresses gastroesophageal reflux disorder than rabeprazole alone. A safe and well-tolerated agent for the treatment of laryngopharyngeal reflux disease. (K Semmanaselvan, 2015) An efficacious drug that provides a significant symptomatic improvement in laryngopharyngeal reflux disease individuals. (K Semmanaselvan, 2015) Improves the quality of life of patients suffering from gastro-esophageal reflux disease. (Savita Shahani, 2008)

Side Effects

Nausea, Pruritus, Abdominal pain, Sleeplessness, Constipation, Headache, Somnolence

Indication

Laryngopharyngeal reflux disease , Gastroesophageal reflux disease , Peptic ulcer disease , Bloating , Regurgitation , Helicobacter pylori infection , Heartburn , Non-erosive reflux disease , Zollinger-Ellison syndrome , Duodenal and gastric ulcers , Intractable nausea and vomiting